Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Garnacho-Montero, J
  • Leon-Moya, C
  • Gutierrez-Pizarraya, A
  • Arenzana-Seisdedos, A
  • Vidaur, L
  • Guerrero, JE
  • Martin-Loeches, I
  • Rodriguez, A
  • GETGAG Study Grp

Grupos

Abstract

Purpose: Information about immunocompromised patients infected with influenza A (H1N1) virus and requiring admission to the ICU is lacking. Our objective was to know the clinical characteristics of these patients and to identify treatment-related variables associated with mortality. Material and methods: A prospective multicenter observational cohort study was based on data from a Spanish registry (2009-2015) collected by 148 Spanish ICUs. All patients admitted to the ICU with the diagnosis of influenza A (H1N1) virus infection were included. Immunosuppression was clearly defined. Factors associated with mortality in immunocompromised patients were assessed by conventional logistic regression analysis and by a propensity score (PS) adjusted-multivariable analysis. Results: Of 1899 patients with influenza A (H1N1 ) infection, 238 (12.5%) were classified as immunocompromised. Mortality was significantly higher in immunosuppressed patients. Four variables independently associated with mortality were identified: SOFA score, need of vasopressor, use of corticosteroids, and acute renal failure, AKIN 3 stage. In the PS-adjusted model, corticosteroid therapy remained as an independent factor associated with increased mortality (OR 2.25;95%CI, 1.15-438;p = 0.017). In the subgroup of hematological patients (n = 141), corticosteroid therapy was also associated with increased mortality (OR 3.12: 95%CI, 1.32-7.41; p = 0.010). Conclusion: Immunocompromised individuals with influenza A ( H1N1) admitted to the ICU have a poor outcome. In this population, the use of corticosteroids is strongly discouraged. (C) 2018 Elsevier Inc. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0883-9441, 1557-8615

JOURNAL OF CRITICAL CARE  W B SAUNDERS CO-ELSEVIER INC

Tipo:
Article
Páginas:
172-177
PubMed:
30216935
Factor de Impacto:
1,118 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 18

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • CRITICALLY-ILL PATIENTS; INFECTIOUS-DISEASES; CORTICOSTEROIDS; MALIGNANCIES; OUTCOMES; FAILURE; SOCIETY; ADULTS

Cita

Compartir